Clinical Trials Sponsored by Donald Trump, MD

Total 21 results

Donald Trump, MD

Terminated

Oral Calcitriol With Ketoconazole in CRPC

Castration-resistant Prostate Cancer

United States
Ronald Kaufman, MD

Completed

Trial of Void With Saline Bladder Instillation

Urethral Catheter Removal After Urologic Procedure

United States
Donald T. Weed, MD, FACS

Completed

PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma

United States
Donald C. Goff, MD
Pfizer

Completed

High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms (HDZ)

Schizophrenia

United States
Ronald M. Benoit, MD

Withdrawn

Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate Cancer

Prostate Cancer

United States
Leonardo Bolognese, MD

Completed

Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation (DEBATE-BTK)

Critical Limb Ischemia

Italy
Ronald Hurst, MD, FACS

Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of LB1148 for Subjects Undergoing Elective Bowel Resection

Ileus | Adhesions

United States
Leonardo Bolognese, MD

Suspended

Drug Eluting Balloon in Peripheral Intervention for In-Stent Restenosis (DEBATE-ISR)

Peripheral Arterial Disease

Italy
Leonardo Bolognese, MD

Completed

Drug Eluting Balloon in peripherAl inTErvention SFA (DEBATE SFA)

Peripheral Arterial Disease

Italy
Leonardo Bolognese, MD

Terminated

A Comparison Between Paclitaxel-eluting Balloon in Combination With BMS Implantation vs Conventional Balloon and DES Implantation (ELICOPTER)

Myocardial Ischemia

Italy
Ronald M Burch MD PhD

Completed

Safety and Tolerability of GATE-251 in Normal Human Volunteers

Major Depressive Disorder
Ronald J. Rapoport, MD
Mallinckrodt

Unknown

Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Craig McDonald, MD
Cardero Therapeutics, Inc.

Completed

(-)- Epicatechin Becker Muscular Dystrophy

Becker Muscular Dystrophy

United States
Craig McDonald, MD
Cardero Therapeutics, Inc.

Completed

Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)

Becker Muscular Dystrophy

United States
Craig McDonald, MD
Cardero Therapeutics, Inc.

Completed

Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents

Duchenne Muscular Dystrophy

United States
Merit E. Cudkowicz, MD
Denali Therapeutics Inc.

Enrolling by invitation

HEALEY ALS Platform Trial - Regimen G DNL343

Amyotrophic Lateral Sclerosis

United States
Ronald M. Glick, MD
Jarrow Formulas Inc; The Fine Foundation

Withdrawn

Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder

Anxiety Disorders | Anxiety | Bipolar Disorder

United States
Ronaldo de Matos Esmeraldo, MD
Novartis Pharmaceuticals

Completed

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

Cytomegalovirus Infections | Transplantation Infection

Brazil
Bristol-Myers Squibb
PPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaborators

Completed

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib (DASCERN)

Chronic Phase Chronic Myeloid Leukemia

Italy, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
Donald Gilbert, MD, MS, FAAN, FAAP
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Recruiting

Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder (AMPAIII)

Attention Deficit Hyperactivity Disorder Combined

United States
Evandro Chagas National Institute of Infectious...
Valdiléa Veloso dos Santos, Ph.D.; Beatriz Grinzstejn, MD, PhD; Brenda Hoagland... and other collaborators

Completed

Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study (Seroincidence)

HIV Infections | Risk Behavior | HIV Seropositivity | Risk Reduction | STD | HIV Infection Primary | Risky Health Behavior

Brazil

Clinical Trials Sponsored by Donald Trump, MD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations